Publicaciones
Investigaciones Biomédicas
1. Development and validation of a quantitative ELISA for the measurement of PSA concentration. Acevedo B, Perera Y, Ruiz M, Rojas G, Benitez J, Ayala M, Gavilondo J.Clin Chim Acta 2002 Mar;317(1-2):55-63
2. In Vitro Self-Assembled HCV Core Virus-like Particles Induce a Strong Antibody Immune Response in Sheep. Acosta-Rivero N, Alvarez-Obregon JC, Musacchio A, Falcon V, Duenas-Carrera S, Marante J, Menendez I, Morales J. 2002.Biochem Biophys Res Commun 2002 Jan 11;290(1):300-4
3. Processing of the Hepatitis C virus precursor protein expressed in the methylotrophic yeast Pichia pastoris. Acosta-Rivero N, Musacchio A, Lorenzo L, Alvarez C, Morales J. Biochem Biophys Res Commun 2002 Jul 5;295(1):81-4
4. Improvement of human interferon HUIFNalpha2 and HCV core protein expression levels in Escherichia coli but not of HUIFNalpha8 by using the tRNA(AGA/AGG). Acosta-Rivero N, Sanchez JC, Morales J.Biochem Biophys Res Commun 2002 Sep 6;296(5):1303-9
5. Additives and protein-DNA combinations modulate the humoral immune response elicited by a hepatitis C virus core-encoding plasmid in mice. Alvarez-Lajonchere L, Duenas-Carrera S, Vina A, Ramos T, Pichardo D, Morales J.Mem Inst Oswaldo Cruz 2002 Jan;97(1):95-9
6. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site. Angles-Cano E, Rojas G.Biol Chem. 2002 Jan;383(1):93-9.
7. Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents. Berlanga J, Lodos J, Lopez-Saura P.Burns 2002 Aug;28(5):435-42
8. Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage. Berlanga J, Prats P, Remirez D, Gonzalez R, Lopez-Saura P, Aguiar J, Ojeda M, Boyle JJ, Fitzgerald AJ, Playford RJ. Am J Pathol 2002 Aug;161(2):373-9
9. Avoiding the genomics divide. Calva E, Cardosa J, Gavilondo JV.Trends Biotechnol 2002 Sep;20(9):368-70
10. Inhibition of unwanted proteolysis during sample preparation: evaluation of its efficiency in challenge experiments. Castellanos-Serra L, Paz-Lago D. Electrophoresis 2002 Jun;23(11):1745-53
11. TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity. Chames P, Willemsen RA, Rojas G, Dieckmann D, Rem L, Schuler G, Bolhuis RL, Hoogenboom HR. J Immunol. 2002 Jul 15;169(2):1110-8.
12. Enhancement of the immune response generated against hepatitis C virus envelope proteins after DNA vaccination with polyprotein-encoding plasmids. Duenas-Carrera S, Alvarez-Lajonchere L, Cesar Alvarez-Obregon J, Perez A, Acosta-Rivero N, Vazquez DM, Martinez G, Vina A, Pichardo D, Morales J.Biotechnol Appl Biochem 2002 Jun;35(Pt 3):205-12
13. High level production of recombinant P64k of Neisseria meningitidis in Escherichia coli. Espinosa R, Caballero E, Musacchio A, Silva R. Biotechnology Letters 2002 24(5):343-346
14. Preformulation study of the vaccine candidate TAB9 against the Human Immunodeficiency Virus type 1 (HIV-1) Expósito N, García A, Carrazana Y, Quintana D, Pichardo D, Martínez N and Duarte C. Biotechnol Appl Biochem 2002 Oct;36(Pt 2):149-53
15. Advances in Nuclear Medicine and Scientific-Technical Quality. Gavilondo JV, Larrick JW. Recombinant Antibodies and Nuclear Medicine (In Spanish). 2002. Ed. José M. Castro Beiras. Fundación Iberomaericana de Salud y Tecnología, Spain. Chapter 42. p777-803
16. An immunoenzymatic solid-phase assay for quantitative determination of HIV-1 protease activity. Gutierrez OA, Salas E, Hernandez Y, Lissi EA, Castrillo G, Reyes O, Garay H, Aguilar A, Garcia B, Otero A, Chavez MA, Duarte CA.Anal Biochem 2002 Aug 1;307(1):18-24
17. A recombinant envelope protein from Dengue virus purified by IMAC is bioequivalent with its immune-affinity chromatography purified counterpart. Hermida L, Rodriguez R, Lazo L, Lopez C, Marquez G, Paez R, Suarez C, Espinosa R, Garcia J, Guzman G, Guillen GJ Biotechnol 2002 Mar 28;94(2):213-6
18. López Marín N, Rodríguez Fernández R . Uso de bibliotecas químicas virtuales para el diseño de medicamentos. Bibliotecas combinatorias. Capítulo 20. Elfos Scientiae.
19. Isolation and characterization of modified species of a mutated (Cys125-Ala) recombinant human interleukin-2. Moya G, González LJ, Huerta V, García Y, Morera V, Pérez D, Breña F, Araña MJ Chromatogr A 2002 Sep 20;971(1-2):129-42
20. TNFalpha production in whole blood cultures from healthy individuals. Ojeda Ojeda M, Silva CV, de J Arana Rosainz M, Fernandez-Ortega CBiochem Biophys Res Commun 2002 Mar 29;292(2):538-41
21. Disposition and receptor-site binding of (125)I-EGF after topical administration to skin wounds. Prats PA, Duconge J, Valenzuela C, Berlanga J, Edrosa CR, Fernandez-Sanchez E.Biopharm Drug Dispos 2002 Mar;23(2):67-76
22. Expression of a single-chain Fv antibody fragment specific for the Hepatitis B surface antigen in transgenic tobacco plants. Ramírez N, Ayala M, Lorenzo D, Palenzuela D, Herrera L, Doreste V, Pérez M, Falcón V, Gavilondo JV, Oramas P .Transgenic Res 2002 Feb;11(1):61-4
23. Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library. Reyes O, Vallespi MG, Garay HE, Cruz LJ, Gonzalez LJ, Chinea G, Buurman W, Arana MJ. J Pept Sci 2002 Apr;8(4):144-50
24. Solid-phase synthesis of 4-aryl substituted 5-carboxy-6-methyl-3,4-dihydropyridones. Rodríguez H, Reyes O, Suarez M, Garay HE, Pérez R, Cruz LJ, Verdecia Y, Martín N, Seoane CTetrahedron Letters 2002 Jan 14;43(3):439-41
25. Phage antibody fragments library combining a single human light chain variable region with immune mouse heavy chain variable regions. Rojas G, Almagro JC, Acevedo B, Gavilondo JV.J Biotechnol 2002 Apr 11;94(3):287-98
26. One-step immunochromatographic assay for screening of coeliac disease. Sorell L, Garrote JA, Acevedo B, Arranz E. Lancet 2002 Mar 16;359(9310):945-6
27. Effect of promoters on cellular immune response induced by recombinant fowlpox virus expressing multi-epitope polypeptides from HIV-1. Vazquez-Blomquist D, Gonzalez S, Duarte CA. Biotechnol Appl Biochem 2002 Dec;36(Pt 3):171-9
28. Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide. Vazquez Blomquist D, Green P, Laidlaw SM, Skinner MA, Borrow P, Duarte CA.Viral Immunol 2002;15(2):337-56
29. Immune response to synthetic peptides of dengue prM protein. Vazquez S, Guzman MG, Guillen G, Chinea G, Perez AB, Pupo M, Rodriguez R, Reyes O, Garay HE, Delgado I, Garcia G, Alvarez M.Vaccine 2002 Mar 15;20(13):1823-30 |
